Phase-III trial of Oxford vaccine to begin in Pune next week
The SII has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: AstraZeneca | COVID-19 | Health | Oxford University | Pharmaceuticals | Sweden Health | UK Health | Vaccines